Reply to letter: Suicide in Parkinson's disease patients treated with levodopa-carbidopa Intestinal Gel
- PMID: 26179940
- PMCID: PMC5034823
- DOI: 10.1002/mds.26316
Reply to letter: Suicide in Parkinson's disease patients treated with levodopa-carbidopa Intestinal Gel
Comment on
-
Levodopa-carbidopa intestinal gel in advanced Parkinson's disease: final 12-month, open-label results.Mov Disord. 2015 Apr;30(4):500-9. doi: 10.1002/mds.26123. Epub 2014 Dec 24. Mov Disord. 2015. PMID: 25545465 Free PMC article. Clinical Trial.
-
Suicide in Parkinson's Disease Patients Treated With Levodopa-Carbidopa Intestinal Gel.Mov Disord. 2015 Sep;30(10):1434-5. doi: 10.1002/mds.26315. Epub 2015 Jul 17. Mov Disord. 2015. PMID: 26184074 No abstract available.
References
-
- Schuepbach WM, Rau J, Knudsen K, et al. Neurostimulation for Parkinson's disease with early motor complications. N Engl J Med 2013;368:610‐622. - PubMed
-
- Di Rocco A, Molinari SP, Kollmeier B, et al. Parkinson's disease: progression and mortality in the L‐DOPA era. Adv Neurol 1996;69:3‐11. - PubMed
-
- Sinemet [package insert]. Whitehouse Station, NJ; Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc; 2011.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
